Brought to you by 
Spinal device companies Baxano and TranS1 merge
23 Sep 2020
Executive Summary
Public spinal device company TranS1 Inc. is merging with closely held Baxano Inc., which also offers minimally invasive devices for conditions of the lumbar spine, in a $25.3mm transaction. TranS1 will issue 10.4mm common shares (valued at $24.75mm) and pay $550k in cash.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
- Payment Includes Stock
- Reverse Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Spinal device companies Baxano and TranS1 merge
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice